[1] Bian Q, Yuan WJ, Lu W, et al.Clinical investigation of the correlation between metabolic Syndrome and chronic disease[J].Chin J Nephrol, 2005, 21(7):389-393. [2] Gassler N, Elger M, Kranzlin B, et al.Podocyte injury underlies the progression of focal segmental glomerulosclerosis in fa fa zucker rats[J].Kidney Int, 2001, 60(1): 106-116. [3] Kasiske BL, O'Donnell MP, Keane WF.The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury[J].Hypertension, 1992, 19(1):110-115. [4] Sowers JR.Metabolic risk factors and renal disease[J]. kidney Int, 2007, 71(8):719-720. [5] SunM, Fan HW, Ma HY, et al.Protective efect of total glucosides of Picrorhiza scrophulariiflora against oxidative stress in glomerular mesangial cells induced by high glucose[J].Acta Pharmaceutica Sinica, 2007, 42(4):381-385. [6] Yuan L, Wu YG, Hao L, et al.Effect of total glucosides of paeony on the expression of intercellular adhesion molecule-1 and transforming growth factor 1 protein in the kidney in experimental diabetes[J].Chin Pharmarcol Bull, 2007, 23(6):821-826. [7] Nakano D, Kwak CJ, Fujii K, et al.Sesamin metabolites induce an endothelial nitric oxide-dependent vasorelaxation through their antioxidative property-independent mechanisms: possible involvement of the metabolites in the antihypertensive effect of sesamin[J].JPET, 2006, 318(1): 328-335. [8] Kawanishi H, Hasegawa Y, Nakano D, et al.Involvement of the endothelin ET (B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension[J].Clin Exp Pharmacol, 2007, 34(4):280-285. [9] Penalvo JL, Hopia A, Adlercreutz H.Effect of sesamin on serum cholesterol and triglycerides levels in LDL receptor-deficient mice[J].Eur J Nutr, 2006, 45 (8):439-444. [10] Hirose N, Inoue T, NishiharaK, et al.Inhibition of cholesterol absorption and synthesis in rats by sesamin[J]. Lipid Res, 1991, 32(4):629-638. [11] Yokota, Matsuzaki Y, Koyama M.Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells[J].Cancer Sci, 2007, 98(9):1447-1453. [12] Kahae Y, Yuuko N, Kumiko K, et al.Sesame seed lignans and y-tocopherol act synergistically to produce vitamin EaActivity in rats[J].Nutr, 1992, 122(8):2440-2446. [13] Ikeda S, Tohyama T, Yamashita K.Dietary sesame seed and its lignans inhibit2, 7, 8-trimethyl-2(2'-carboxyethy l)-6-hydroxychroman excretion into urine of rats fed γ-tocopherol[J].Nutr, 2002, 132(5):961-966. [14] Ghafoorunissa, Hemalatha S, Rao MV.Sesame lignans enhance antioxidant activity of vitamin E in lipid peroxidation systems[J].Mol Cell Biochem, 2004, 262(1/2):195-202. [15] Yanardag R, Ozsoy-Sacan O, Ozdil S, et al.Combined effects of vitamin C, vitamin e, and sodium selenate supplementation on absolute ethanol-induced injury in various organs of rats[J].Int J Toxicol, 2007, 26(6):513-523. [16] Kunitomo M.Oxidative stress and atherosclerosis[J]. Yakugaku Zasshi, 2007, 127(12):1997-2014. [17] Lai YR, Tao Y, Liang YJ.The investigation of routine staining procedure for renal biopsy[J].JPMT, 2006, 13 (14):2398-2399. [18] Barnard R, James, Christian K, et al.Diet-induced insulin resistance precedes other aspect of the metabolic syndrome[J].Appl Physiol, 1998, 84(4):1311-1315. [19] Wang YT, Chen XH.Metabolic syndrme and kidney damage[J].Chin J Pract Intern Med, 2006, 26(23):1898-1900. [20] Li Y.Metabolic syndrme and kidney damage[J].Lab Med Clin, 2007, 4(2):111-112. [21] Dominguez JH, Wu P, Hawes JW, et al.Renal injury: similarities and differences in male and female rats with the metabolic syndrome[J].Kidney Int, 2006, 69(11):1969-1976. [22] Nakabayashi A, Kitagawa Y, Suwa Y, et al.Alfa-tocopherol enhances the hypocholesterolemic action of sesamin in rats[J].Int J Vit Nutr Res, 1995, 65(3):162-168. [23] Noguchi T, Ikeda K, Sasaki Y, et al.Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats[J].Clin Exp Pharmacol Physicol, 2004, 31(Suppl 2):S24-26. [24] Wu XQ, Yang JR.Antioxidation and renoprotective effect of sesamin in metabolic syndrome rats[J].Chin Pharmarcol Bull, 2008, 24(8):1065-1069. |